Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of deferasirox administration regimens for gastrointestinal tolerability in low- or intermediate-1-risk myelodysplastic syndrome with transfusional iron overload
2011-001077-13Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox in iron overload, sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
deferasirox
03
Conditions
iron overload
Beyond the preview
Go deeper on 2011-001077-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001077-13.